Global Organ Transplantation Market

Organ Transplantation Comprehensive Study by Type (Preservation Solutions, Transplant Diagnostics, Tissue Products, Others (Immunosuppressive drugs)), Application (Children, Adults, Senior Citizens), Organ Type (Heart, Kidney, Liver, Lungs, Other), End user (Hospitals, Transplant centers, Others), Type of Transplant (Autograft, Allograft and Allotransplantation, Xenograft and Xenotransplantation, Other) Players and Region - Global Market Outlook to 2028

Organ Transplantation Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Organ Transplantation
Organ transplantation refers to the replacement of the diseased or damaged organ with a healthy organ. The organs may be donated by live donors or harvested from a brain dead organ donors. Organ dysfunction caused due to severe injuries cancer, organ failure and/or genetic disorders necessitates the requirement for organ transplant procedures.

AttributesDetails
Study Period2018-2028
Base Year2022
High Growth MarketAsia-Pacific
UnitValue (USD Billion)


Ongoing awareness of developments in medical technologies is integral to understanding and utilizing the best options available. Development in the field of organ transplantation such as machine reperfusion of organs have the potential to transform and increase the opportunities for patients needing a transplant. Repair and regeneration of organs will have a substantial impact on the number of suitable organ donors. Both mechanical and biological (stem cell) organ replacement therapies may change the profile of people needing an organ transplant. Work with the eye and tissue banking sector will continue to foster a strong national network, and consistency and sustainability of the sector. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Organ Transplantation market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Bio Med Pvt. Ltd. (United States), Terumo Medical Corporation (United States), Preservation Solutions, Inc. (United States), Transonic (United States), Pfizer, Inc. (United States), TransMedic, Inc. (United States), GlaxoSmithKline Plc. (United Kingdom), OrganOX Limited (United Kingdom), Transplant Biomedical (United Kingdom), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland) and Accord Healthcare GmbH (Spain) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Astellas Pharma, Inc (Japan) and Veloxis Pharmaceuticals A/S (Denmark).

Segmentation Overview
AMA Research has segmented the market of Global Organ Transplantation market by Type (Preservation Solutions, Transplant Diagnostics, Tissue Products and Others (Immunosuppressive drugs)), Application (Children, Adults and Senior Citizens) and Region. On the basis of Type, Tissue Product are dominating the market in the year 2022



On the basis of geography, the market of Organ Transplantation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2022. Europe, on the other hand, stood as the second largest market due to the presence of key companies in the region and high technological advancement. If we see Market by Organ Type, the sub-segment i.e. Heart will boost the Organ Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End user, the sub-segment i.e. Hospitals will boost the Organ Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Type of Transplant , the sub-segment i.e. Autograft will boost the Organ Transplantation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Technology Advancement and Innovation In Medical Sector and Organ and Tissue Procurement And Its preservation

Market Growth Drivers:
Increasing Number of Chronic Diseases and Organ Failure, Growing Consumption of Alcohol and Unhealthy Diet and Increasing Relevance of Renal Diseases

Challenges:
Huge Gap Between Demand and Supply For Organ Transplantation

Restraints:
High Cost of Transplantation, Limited Number of Donors and Increasing Incidences And Organ Failure

Opportunities:
Rising Aging Population and Changing Lifestyle

Organs that have been successfully transplanted include the heart, kidneys, brain, liver, lungs, pancreas, intestine, and thymus. From the year 2000 and forward, there have been approximately 2,200 lung transplants performed each year worldwide. From between 2000 and 2006, the median survival period for lung transplant patients has been 5-and-a-half years, meaning half the patients survived for a shorter time period and a half survived for a longer period. In China, a kidney transplant operation runs for around USD 70,000, liver for USD 160,000, and heart for USD 120,000. Although these prices are still unattainable to the poor, compared to the fees of the United States, where a kidney transplant may demand USD 100,000, a liver USD 250,000, and a heart USD 860,000, Chinese prices have made China a major provider of organs and transplantation surgeries to other countries.
According to National Kidney Foundation “Around 3,000 new patients are added to the kidney waiting list each month worldwide.” According to the United Network for organ sharing, in the United States every day 21 people die to wait for an organ, and more than 120,000 men, women, and children await lifesaving organ transplants. and According to the Health Resources and Services Administration, till May 2017, there were around 117,829 patients waiting for organ transplants in the U.S., among them about 97,610 were waiting for kidney transplants. However, only 11,061 transplant procedures were performed from January to April 2017.

Key Target Audience
Pharmaceutical Companies, Research and Development (R&D) Companies, Independent Research Laboratories, Market Research and Consulting Service Providers, Medical Research Laboratories, Academic Medical Institutes and Universities and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Preservation Solutions
  • Transplant Diagnostics
  • Tissue Products
  • Others (Immunosuppressive drugs)
By Application
  • Children
  • Adults
  • Senior Citizens
By Organ Type
  • Heart
  • Kidney
  • Liver
  • Lungs
  • Other

By End user
  • Hospitals
  • Transplant centers
  • Others

By Type of Transplant
  • Autograft
  • Allograft and Allotransplantation
  • Xenograft and Xenotransplantation
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Chronic Diseases and Organ Failure
      • 3.2.2. Growing Consumption of Alcohol and Unhealthy Diet
      • 3.2.3. Increasing Relevance of Renal Diseases
    • 3.3. Market Challenges
      • 3.3.1. Huge Gap Between Demand and Supply For Organ Transplantation
    • 3.4. Market Trends
      • 3.4.1. Technology Advancement and Innovation In Medical Sector
      • 3.4.2. Organ and Tissue Procurement And Its preservation
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Organ Transplantation, by Type, Application, Organ Type, End user, Type of Transplant and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Organ Transplantation (Value)
      • 5.2.1. Global Organ Transplantation by: Type (Value)
        • 5.2.1.1. Preservation Solutions
        • 5.2.1.2. Transplant Diagnostics
        • 5.2.1.3. Tissue Products
        • 5.2.1.4. Others (Immunosuppressive drugs)
      • 5.2.2. Global Organ Transplantation by: Application (Value)
        • 5.2.2.1. Children
        • 5.2.2.2. Adults
        • 5.2.2.3. Senior Citizens
      • 5.2.3. Global Organ Transplantation by: Organ Type (Value)
        • 5.2.3.1. Heart
        • 5.2.3.2. Kidney
        • 5.2.3.3. Liver
        • 5.2.3.4. Lungs
        • 5.2.3.5. Other
      • 5.2.4. Global Organ Transplantation by: End user (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Transplant centers
        • 5.2.4.3. Others
      • 5.2.5. Global Organ Transplantation Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Organ Transplantation: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Bio Med Pvt. Ltd. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Terumo Medical Corporation (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Preservation Solutions, Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Transonic (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. TransMedic, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. GlaxoSmithKline Plc. (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. OrganOX Limited (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Transplant Biomedical (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Novartis International AG (Switzerland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Sanofi (France)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. F. Hoffmann-La Roche Ltd. (Switzerland)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Accord Healthcare GmbH (Spain)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
  • 7. Global Organ Transplantation Sale, by Type, Application, Organ Type, End user, Type of Transplant and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Organ Transplantation (Value)
      • 7.2.1. Global Organ Transplantation by: Type (Value)
        • 7.2.1.1. Preservation Solutions
        • 7.2.1.2. Transplant Diagnostics
        • 7.2.1.3. Tissue Products
        • 7.2.1.4. Others (Immunosuppressive drugs)
      • 7.2.2. Global Organ Transplantation by: Application (Value)
        • 7.2.2.1. Children
        • 7.2.2.2. Adults
        • 7.2.2.3. Senior Citizens
      • 7.2.3. Global Organ Transplantation by: Organ Type (Value)
        • 7.2.3.1. Heart
        • 7.2.3.2. Kidney
        • 7.2.3.3. Liver
        • 7.2.3.4. Lungs
        • 7.2.3.5. Other
      • 7.2.4. Global Organ Transplantation by: End user (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Transplant centers
        • 7.2.4.3. Others
      • 7.2.5. Global Organ Transplantation Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Organ Transplantation: by Type(USD Billion)
  • Table 2. Organ Transplantation Preservation Solutions , by Region USD Billion (2017-2022)
  • Table 3. Organ Transplantation Transplant Diagnostics , by Region USD Billion (2017-2022)
  • Table 4. Organ Transplantation Tissue Products , by Region USD Billion (2017-2022)
  • Table 5. Organ Transplantation Others (Immunosuppressive drugs) , by Region USD Billion (2017-2022)
  • Table 6. Organ Transplantation: by Application(USD Billion)
  • Table 7. Organ Transplantation Children , by Region USD Billion (2017-2022)
  • Table 8. Organ Transplantation Adults , by Region USD Billion (2017-2022)
  • Table 9. Organ Transplantation Senior Citizens , by Region USD Billion (2017-2022)
  • Table 10. Organ Transplantation: by Organ Type(USD Billion)
  • Table 11. Organ Transplantation Heart , by Region USD Billion (2017-2022)
  • Table 12. Organ Transplantation Kidney , by Region USD Billion (2017-2022)
  • Table 13. Organ Transplantation Liver , by Region USD Billion (2017-2022)
  • Table 14. Organ Transplantation Lungs , by Region USD Billion (2017-2022)
  • Table 15. Organ Transplantation Other , by Region USD Billion (2017-2022)
  • Table 16. Organ Transplantation: by End user(USD Billion)
  • Table 17. Organ Transplantation Hospitals , by Region USD Billion (2017-2022)
  • Table 18. Organ Transplantation Transplant centers , by Region USD Billion (2017-2022)
  • Table 19. Organ Transplantation Others , by Region USD Billion (2017-2022)
  • Table 20. South America Organ Transplantation, by Country USD Billion (2017-2022)
  • Table 21. South America Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 22. South America Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 23. South America Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 24. South America Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 25. South America Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 26. Brazil Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 27. Brazil Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 28. Brazil Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 29. Brazil Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 30. Brazil Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 31. Argentina Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 32. Argentina Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 33. Argentina Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 34. Argentina Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 35. Argentina Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 36. Rest of South America Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 37. Rest of South America Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 38. Rest of South America Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 39. Rest of South America Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 40. Rest of South America Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 41. Asia Pacific Organ Transplantation, by Country USD Billion (2017-2022)
  • Table 42. Asia Pacific Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 43. Asia Pacific Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 44. Asia Pacific Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 45. Asia Pacific Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 46. Asia Pacific Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 47. China Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 48. China Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 49. China Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 50. China Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 51. China Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 52. Japan Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 53. Japan Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 54. Japan Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 55. Japan Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 56. Japan Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 57. India Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 58. India Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 59. India Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 60. India Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 61. India Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 62. South Korea Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 63. South Korea Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 64. South Korea Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 65. South Korea Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 66. South Korea Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 67. Taiwan Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 68. Taiwan Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 69. Taiwan Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 70. Taiwan Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 71. Taiwan Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 72. Australia Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 73. Australia Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 74. Australia Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 75. Australia Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 76. Australia Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 77. Rest of Asia-Pacific Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 78. Rest of Asia-Pacific Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 79. Rest of Asia-Pacific Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 80. Rest of Asia-Pacific Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 81. Rest of Asia-Pacific Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 82. Europe Organ Transplantation, by Country USD Billion (2017-2022)
  • Table 83. Europe Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 84. Europe Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 85. Europe Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 86. Europe Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 87. Europe Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 88. Germany Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 89. Germany Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 90. Germany Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 91. Germany Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 92. Germany Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 93. France Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 94. France Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 95. France Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 96. France Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 97. France Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 98. Italy Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 99. Italy Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 100. Italy Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 101. Italy Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 102. Italy Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 103. United Kingdom Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 104. United Kingdom Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 105. United Kingdom Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 106. United Kingdom Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 107. United Kingdom Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 108. Netherlands Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 109. Netherlands Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 110. Netherlands Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 111. Netherlands Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 112. Netherlands Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 113. Rest of Europe Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 114. Rest of Europe Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 115. Rest of Europe Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 116. Rest of Europe Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 117. Rest of Europe Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 118. MEA Organ Transplantation, by Country USD Billion (2017-2022)
  • Table 119. MEA Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 120. MEA Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 121. MEA Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 122. MEA Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 123. MEA Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 124. Middle East Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 125. Middle East Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 126. Middle East Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 127. Middle East Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 128. Middle East Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 129. Africa Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 130. Africa Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 131. Africa Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 132. Africa Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 133. Africa Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 134. North America Organ Transplantation, by Country USD Billion (2017-2022)
  • Table 135. North America Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 136. North America Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 137. North America Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 138. North America Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 139. North America Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 140. United States Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 141. United States Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 142. United States Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 143. United States Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 144. United States Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 145. Canada Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 146. Canada Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 147. Canada Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 148. Canada Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 149. Canada Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 150. Mexico Organ Transplantation, by Type USD Billion (2017-2022)
  • Table 151. Mexico Organ Transplantation, by Application USD Billion (2017-2022)
  • Table 152. Mexico Organ Transplantation, by Organ Type USD Billion (2017-2022)
  • Table 153. Mexico Organ Transplantation, by End user USD Billion (2017-2022)
  • Table 154. Mexico Organ Transplantation, by Type of Transplant USD Billion (2017-2022)
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Company Basic Information, Sales Area and Its Competitors
  • Table 163. Company Basic Information, Sales Area and Its Competitors
  • Table 164. Company Basic Information, Sales Area and Its Competitors
  • Table 165. Company Basic Information, Sales Area and Its Competitors
  • Table 166. Company Basic Information, Sales Area and Its Competitors
  • Table 167. Company Basic Information, Sales Area and Its Competitors
  • Table 168. Organ Transplantation: by Type(USD Billion)
  • Table 169. Organ Transplantation Preservation Solutions , by Region USD Billion (2023-2028)
  • Table 170. Organ Transplantation Transplant Diagnostics , by Region USD Billion (2023-2028)
  • Table 171. Organ Transplantation Tissue Products , by Region USD Billion (2023-2028)
  • Table 172. Organ Transplantation Others (Immunosuppressive drugs) , by Region USD Billion (2023-2028)
  • Table 173. Organ Transplantation: by Application(USD Billion)
  • Table 174. Organ Transplantation Children , by Region USD Billion (2023-2028)
  • Table 175. Organ Transplantation Adults , by Region USD Billion (2023-2028)
  • Table 176. Organ Transplantation Senior Citizens , by Region USD Billion (2023-2028)
  • Table 177. Organ Transplantation: by Organ Type(USD Billion)
  • Table 178. Organ Transplantation Heart , by Region USD Billion (2023-2028)
  • Table 179. Organ Transplantation Kidney , by Region USD Billion (2023-2028)
  • Table 180. Organ Transplantation Liver , by Region USD Billion (2023-2028)
  • Table 181. Organ Transplantation Lungs , by Region USD Billion (2023-2028)
  • Table 182. Organ Transplantation Other , by Region USD Billion (2023-2028)
  • Table 183. Organ Transplantation: by End user(USD Billion)
  • Table 184. Organ Transplantation Hospitals , by Region USD Billion (2023-2028)
  • Table 185. Organ Transplantation Transplant centers , by Region USD Billion (2023-2028)
  • Table 186. Organ Transplantation Others , by Region USD Billion (2023-2028)
  • Table 187. South America Organ Transplantation, by Country USD Billion (2023-2028)
  • Table 188. South America Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 189. South America Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 190. South America Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 191. South America Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 192. South America Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 193. Brazil Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 194. Brazil Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 195. Brazil Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 196. Brazil Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 197. Brazil Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 198. Argentina Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 199. Argentina Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 200. Argentina Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 201. Argentina Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 202. Argentina Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 203. Rest of South America Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 204. Rest of South America Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 205. Rest of South America Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 206. Rest of South America Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 207. Rest of South America Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 208. Asia Pacific Organ Transplantation, by Country USD Billion (2023-2028)
  • Table 209. Asia Pacific Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 210. Asia Pacific Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 211. Asia Pacific Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 212. Asia Pacific Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 213. Asia Pacific Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 214. China Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 215. China Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 216. China Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 217. China Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 218. China Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 219. Japan Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 220. Japan Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 221. Japan Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 222. Japan Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 223. Japan Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 224. India Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 225. India Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 226. India Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 227. India Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 228. India Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 229. South Korea Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 230. South Korea Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 231. South Korea Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 232. South Korea Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 233. South Korea Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 234. Taiwan Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 235. Taiwan Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 236. Taiwan Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 237. Taiwan Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 238. Taiwan Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 239. Australia Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 240. Australia Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 241. Australia Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 242. Australia Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 243. Australia Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 244. Rest of Asia-Pacific Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 245. Rest of Asia-Pacific Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 246. Rest of Asia-Pacific Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 247. Rest of Asia-Pacific Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 248. Rest of Asia-Pacific Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 249. Europe Organ Transplantation, by Country USD Billion (2023-2028)
  • Table 250. Europe Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 251. Europe Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 252. Europe Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 253. Europe Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 254. Europe Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 255. Germany Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 256. Germany Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 257. Germany Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 258. Germany Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 259. Germany Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 260. France Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 261. France Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 262. France Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 263. France Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 264. France Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 265. Italy Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 266. Italy Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 267. Italy Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 268. Italy Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 269. Italy Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 270. United Kingdom Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 271. United Kingdom Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 272. United Kingdom Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 273. United Kingdom Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 274. United Kingdom Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 275. Netherlands Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 276. Netherlands Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 277. Netherlands Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 278. Netherlands Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 279. Netherlands Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 280. Rest of Europe Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 281. Rest of Europe Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 282. Rest of Europe Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 283. Rest of Europe Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 284. Rest of Europe Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 285. MEA Organ Transplantation, by Country USD Billion (2023-2028)
  • Table 286. MEA Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 287. MEA Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 288. MEA Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 289. MEA Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 290. MEA Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 291. Middle East Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 292. Middle East Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 293. Middle East Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 294. Middle East Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 295. Middle East Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 296. Africa Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 297. Africa Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 298. Africa Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 299. Africa Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 300. Africa Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 301. North America Organ Transplantation, by Country USD Billion (2023-2028)
  • Table 302. North America Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 303. North America Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 304. North America Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 305. North America Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 306. North America Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 307. United States Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 308. United States Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 309. United States Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 310. United States Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 311. United States Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 312. Canada Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 313. Canada Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 314. Canada Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 315. Canada Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 316. Canada Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 317. Mexico Organ Transplantation, by Type USD Billion (2023-2028)
  • Table 318. Mexico Organ Transplantation, by Application USD Billion (2023-2028)
  • Table 319. Mexico Organ Transplantation, by Organ Type USD Billion (2023-2028)
  • Table 320. Mexico Organ Transplantation, by End user USD Billion (2023-2028)
  • Table 321. Mexico Organ Transplantation, by Type of Transplant USD Billion (2023-2028)
  • Table 322. Research Programs/Design for This Report
  • Table 323. Key Data Information from Secondary Sources
  • Table 324. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Organ Transplantation: by Type USD Billion (2017-2022)
  • Figure 5. Global Organ Transplantation: by Application USD Billion (2017-2022)
  • Figure 6. Global Organ Transplantation: by Organ Type USD Billion (2017-2022)
  • Figure 7. Global Organ Transplantation: by End user USD Billion (2017-2022)
  • Figure 8. South America Organ Transplantation Share (%), by Country
  • Figure 9. Asia Pacific Organ Transplantation Share (%), by Country
  • Figure 10. Europe Organ Transplantation Share (%), by Country
  • Figure 11. MEA Organ Transplantation Share (%), by Country
  • Figure 12. North America Organ Transplantation Share (%), by Country
  • Figure 13. Global Organ Transplantation share by Players 2022 (%)
  • Figure 14. Global Organ Transplantation share by Players (Top 3) 2022(%)
  • Figure 15. Global Organ Transplantation share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Bio Med Pvt. Ltd. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Bio Med Pvt. Ltd. (United States) Revenue: by Geography 2022
  • Figure 19. Terumo Medical Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 20. Terumo Medical Corporation (United States) Revenue: by Geography 2022
  • Figure 21. Preservation Solutions, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. Preservation Solutions, Inc. (United States) Revenue: by Geography 2022
  • Figure 23. Transonic (United States) Revenue, Net Income and Gross profit
  • Figure 24. Transonic (United States) Revenue: by Geography 2022
  • Figure 25. Pfizer, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer, Inc. (United States) Revenue: by Geography 2022
  • Figure 27. TransMedic, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. TransMedic, Inc. (United States) Revenue: by Geography 2022
  • Figure 29. GlaxoSmithKline Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 30. GlaxoSmithKline Plc. (United Kingdom) Revenue: by Geography 2022
  • Figure 31. OrganOX Limited (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. OrganOX Limited (United Kingdom) Revenue: by Geography 2022
  • Figure 33. Transplant Biomedical (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Transplant Biomedical (United Kingdom) Revenue: by Geography 2022
  • Figure 35. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 36. Novartis International AG (Switzerland) Revenue: by Geography 2022
  • Figure 37. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 38. Sanofi (France) Revenue: by Geography 2022
  • Figure 39. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 40. F. Hoffmann-La Roche Ltd. (Switzerland) Revenue: by Geography 2022
  • Figure 41. Accord Healthcare GmbH (Spain) Revenue, Net Income and Gross profit
  • Figure 42. Accord Healthcare GmbH (Spain) Revenue: by Geography 2022
  • Figure 43. Global Organ Transplantation: by Type USD Billion (2023-2028)
  • Figure 44. Global Organ Transplantation: by Application USD Billion (2023-2028)
  • Figure 45. Global Organ Transplantation: by Organ Type USD Billion (2023-2028)
  • Figure 46. Global Organ Transplantation: by End user USD Billion (2023-2028)
  • Figure 47. South America Organ Transplantation Share (%), by Country
  • Figure 48. Asia Pacific Organ Transplantation Share (%), by Country
  • Figure 49. Europe Organ Transplantation Share (%), by Country
  • Figure 50. MEA Organ Transplantation Share (%), by Country
  • Figure 51. North America Organ Transplantation Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Bio Med Pvt. Ltd. (United States)
  • Terumo Medical Corporation (United States)
  • Preservation Solutions, Inc. (United States)
  • Transonic (United States)
  • Pfizer, Inc. (United States)
  • TransMedic, Inc. (United States)
  • GlaxoSmithKline Plc. (United Kingdom)
  • OrganOX Limited (United Kingdom)
  • Transplant Biomedical (United Kingdom)
  • Novartis International AG (Switzerland)
  • Sanofi (France)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Accord Healthcare GmbH (Spain)
Additional players considered in the study are as follows:
Astellas Pharma, Inc (Japan) , Veloxis Pharmaceuticals A/S (Denmark)
Select User Access Type

Key Highlights of Report


Nov 2023 248 Pages 57 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Organ Transplantation Market Quantitative research analysis
Global Organ Transplantation Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Bio Med Pvt. Ltd. (United States), Terumo Medical Corporation (United States), Preservation Solutions, Inc. (United States), Transonic (United States), Pfizer, Inc. (United States), TransMedic, Inc. (United States), GlaxoSmithKline Plc. (United Kingdom), OrganOX Limited (United Kingdom), Transplant Biomedical (United Kingdom), Novartis International AG (Switzerland), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland) and Accord Healthcare GmbH (Spain) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Technology Advancement and Innovation In Medical Sector " is seen as one of major influencing trends for Organ Transplantation Market during projected period 2022-2028.
The Organ Transplantation market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Organ Transplantation Market Report?

Have a Query? Click Here

Other Related Reports

Nocturia Comprehensive Study by Type (Nocturnal Polyuria, Bladder Storage Problems, Mixed Nocturia), Application (Hospitals, Clinics), Drug Form (Tablets, Nasal Spray), Types (Polyuria, Nocturnal Pol...
$ 3650
Shoulder Labrum Repair Comprehensive Study by Type (PLA Resorbable Suture Anchor, Biocomposite Suture Anchor, PEEK Suture Anchor, Metal Suture Anchor, All-Suture Anchor), Application (Rotator Cuff Te...
$ 3650
Breast Biopsy Comprehensive Study by Type (Core Needle Biopsy (CNB), Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy (FNAB)), Application (Hospitals, Clinics, Diagnostic Centers, Others),...
$ 3750
Antiretroviral Therapy Comprehensive Study by Route of Administration (Oral, Parenteral), Class (Nucleoside Reverse Transcriptase Inhibitors, HIV Protease Inhibitors, Non-nucleoside Reverse Transcrip...
$ 3650
CD Antigen Cancer Therapy Comprehensive Study by Type (Monoclonal Antibodies, Antibody-Drug-Conjugates, Tri-Functional & Bi-Specific T-Cell Engager Antibodies, Other), Application (Hospitals, Homecar...
$ 3750
Neuroprotection Comprehensive Study by Type (Free Radical Trapping Agents (Antioxidants), Glutamate Antagonists (Anti-Excitotoxic Agents), Apoptosis Inhibitors, Anti-inflammatory Agents, Neurotrophic...
$ 3750